<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00155909</url>
  </required_header>
  <id_info>
    <org_study_id>9261700803</org_study_id>
    <secondary_id>NTUH-92N013</secondary_id>
    <nct_id>NCT00155909</nct_id>
  </id_info>
  <brief_title>Risk Factors of Radiation Pneumonitis</brief_title>
  <official_title>To Investigate Risk Factors of Radiation Pneumonitis, Fibrosis, and Impairment of Quality of Life by Radiotherapeutic Dosimetric and Biological Parameters for Lung Cancer Patients Receiving Thoracic Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      A prospective observational study to evaluate clinical, dosimetrical, functional, and
      biological factors in predicting radiation pneumonitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose a prospective observational study to investigate the combinational effect of
      radiotherapeutic dosimetric parameters [mean lung dose &amp; percentage of lung volume receiving
      at least 20Gy (V20)] and biological parameters [interleukin-6(IL6) &amp; transforming growth
      factor beta (TGFB)] in predicting radiation pneumonitis, fibrosis, and change of QoL among at
      least fifty-three lung cancer patients. Eligibility included pathological or cytological
      proven small cell or non small cell lung cancer, thoracic RT planned for more than 30Gy [if
      fraction size &gt;= 3Gy/fx] or 40Gy [if fraction size &lt; 3 Gy/Fx], ECOG performance status [PS]
      0-2, body weight loss [BWL] &lt;=10% in previous 6 months, no prior thoracic RT and signed
      informed consent prior to study entry. Basic pre-radiotherapy information will be collected,
      which included BWL, ECOG PS, AJCC stage [I-IV], primary lesion site, history of
      smoking/coexisting lung disease/dosage of chemotherapy/surgical resection, albumin level, and
      pulmonary function test of FEV1/VC/DLCO(optional). Computed tomography [CT] of the whole lung
      in treatment position with reference mark will be done for calculation of V20 and mean lung
      dose. Blood test of IL6, TGFB by ELISA will be done before and after RT after storage at
      -80â„ƒ. Bronchial-alveolar lavage test of IL6, TGFB by ELISA will be done before and after RT
      if clinical available. Self-reported questionnaire [EORTC C30 &amp; L13] will be collected before
      and after RT and in every follow up visits after double-checked by trained assistants. RT
      must be given by photon energies &gt;=6MV. Radiation pneumonitis and fibrosis will be assessed
      according to common toxicity criteria 3 [CTC-3] weekly during RT and in every follow up
      visits. Chi-square test, logistic regression, and proportional hazard ratio method will be
      used to investigate whether the parameter(s) can be effective in predicting radiation related
      sequelae.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2003</start_date>
  <completion_date>June 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>53</enrollment>
  <condition>Radiation Pneumonitis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-pregnant adults (age &gt;=20 y/o)

          -  Pathological or cytological proven small cell or non small cell lung cancer

          -  Thoracic RT planned for more than 30Gy [if fraction size &gt;= 3Gy/fx] or 40Gy [if
             fraction size &lt; 3 Gy/Fx]

          -  ECOG PS 0-2

          -  Body weight loss &lt;=10% in previous 6 months

        Exclusion Criteria:

          -  prior thoracic RT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun-Ru Chien, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chun-Ru Chien, M.D.</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>2643</phone_ext>
    <email>stwo@ha.mc.ntu.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wei-Chu Chie, M.D.and PhD</last_name>
    <phone>886-2-23516478</phone>
    <phone_ext>26</phone_ext>
    <email>weichu@episerv.cph.ntu.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chun-Ru Chien, MD</last_name>
      <phone>886-23123456</phone>
      <phone_ext>2643</phone_ext>
      <email>stwo@ha.mc.ntu.edu.tw</email>
    </contact>
    <contact_backup>
      <last_name>Wei Chu Chie, M.D., Ph.D.</last_name>
      <phone>886-2-23516478</phone>
      <phone_ext>26</phone_ext>
      <email>weichu@episerv.cph.ntu.edu.tw</email>
    </contact_backup>
    <investigator>
      <last_name>Chun-Ru Chien, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>November 22, 2005</last_update_submitted>
  <last_update_submitted_qc>November 22, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2005</last_update_posted>
  <keyword>Radiation Pneumonitis</keyword>
  <keyword>Radiotherapy Planning, Computer-Assisted</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Radiation Pneumonitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

